Jeff Garro
Stock Analyst at Stephens & Co.
(0.78)
# 3,823
Out of 4,876 analysts
49
Total ratings
30.3%
Success rate
-13.64%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $23.59 | +18.69% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $281.19 | -0.42% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.75 | +33.51% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.42 | +48.86% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $10.75 | +11.63% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $22.00 | +18.18% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.79 | +31.93% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $60.41 | -8.96% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $12.65 | -56.52% | 3 | Dec 20, 2024 | |
| IQV IQVIA Holdings | Initiates: Overweight | $250 | $158.16 | +58.07% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $15.18 | +11.99% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $17.12 | +127.80% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $27.95 | +0.18% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.05 | +247.83% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $13.76 | +45.35% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.94 | -1.02% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.31 | +29.87% | 3 | May 6, 2022 |
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $23.59
Upside: +18.69%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $281.19
Upside: -0.42%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.75
Upside: +33.51%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.42
Upside: +48.86%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $10.75
Upside: +11.63%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $22.00
Upside: +18.18%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.79
Upside: +31.93%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $60.41
Upside: -8.96%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $12.65
Upside: -56.52%
IQVIA Holdings
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $158.16
Upside: +58.07%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $15.18
Upside: +11.99%
Nov 15, 2024
Initiates: Overweight
Price Target: $39
Current: $17.12
Upside: +127.80%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $27.95
Upside: +0.18%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.05
Upside: +247.83%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $13.76
Upside: +45.35%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.94
Upside: -1.02%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.31
Upside: +29.87%